NICM
NVAX icon

Neo Ivy Capital Management’s Novavax NVAX Stock Holding History

Neo Ivy Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56,460
Closed -$714K – 364
2024
Q3 		$714K Buy
+56,460
New +$729K 0.23% 169
2022
Q4 		– Sell
-2,021
Closed -$37K – 490
2022
Q3 		$37K Buy
+2,021
New +$87.6K 0.1% 255
2022
Q2 		– Sell
-1,348
Closed -$100K – 548
2022
Q1 		$100K Buy
1,348
+1,181
+707% +$105K 0.09% 302
2021
Q4 		$24K Sell
167
-99
-37% -$17K 0.03% 350
2021
Q3 		$22K Sell
266
-332
-56% -$73.2K 0.03% 390
2021
Q2 		$127K Buy
+598
New +$110K 0.13% 232
2021
Q1 		– Sell
-359
Closed -$40K – 587
2020
Q4 		$40K Buy
359
+357
+17,850% +$37.9K 0.04% 325
2020
Q3 		$0 Sell
2
-264
-99% -$32.2K ﹤0.01% 569
2020
Q2 		$22K Buy
+266
New +$10.2K 0.03% 390

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Neo Ivy Capital Management's NVAX Position: Q4 2024 in Review

Neo Ivy Capital Management sold out of Novavax (NVAX) in Q4 2024, closing a stake of 56,460 shares — an estimated $714K sold.

Neo Ivy Capital Management first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $714K in Q3 2024. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Neo Ivy Capital Management reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Neo Ivy Capital Management sold 56,460 Novavax shares in Q4 2024, an estimated $714K.
  • Neo Ivy Capital Management first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
  • Neo Ivy Capital Management's Novavax position peaked at $714K in Q3 2024.
  • 234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Neo Ivy Capital Management's 13F filing for Q4 2024, filed 18 Feb 2025.